tiprankstipranks
Advertisement
Advertisement

Genus discloses executive share vesting and tax-related sale

Story Highlights
  • Genus plc reported that COO Jim Low had 7,307 share awards vest and release under a Restricted Stock Award.
  • Low sold 2,756 shares solely to cover tax liabilities, retaining 4,551 shares, in a routine disclosed transaction.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Genus discloses executive share vesting and tax-related sale

Meet Samuel – Your Personal Investing Prophet

An update from Genus plc ( (GB:GNS) ) is now available.

Genus plc has disclosed a routine share transaction involving Jim Low, Chief Operating Officer of its ABS division, following the vesting of a previously granted Restricted Stock Award. On 31 March 2026, 7,307 share awards vested and were released to Low, who then sold 2,756 shares on the London Stock Exchange at 2,405p each to cover income tax and social security liabilities, retaining 4,551 shares, in line with market abuse regulation disclosure requirements.

The transaction underscores standard executive compensation practices at the company and provides transparency to investors regarding management’s equity holdings. As the sale was strictly to meet tax obligations and not an outright disposal of the entire award, it is unlikely to signal any change in strategic outlook or confidence, but it does slightly increase the free float while maintaining significant equity alignment between the executive and shareholders.

The most recent analyst rating on (GB:GNS) stock is a Buy with a £3350.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.

Spark’s Take on GNS Stock

According to Spark, TipRanks’ AI Analyst, GNS is a Neutral.

Genus plc’s overall stock score is driven by strong corporate events and solid financial performance. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates possible overvaluation.

To see Spark’s full report on GNS stock, click here.

More about Genus plc

Genus plc is a London-listed company operating in the agricultural biotechnology and animal genetics sector. It develops and supplies genetic products and services aimed at improving livestock herds, with a particular focus on cattle through its ABS division, where senior executives such as the Chief Operating Officer play key operational roles.

Average Trading Volume: 200,595

Technical Sentiment Signal: Hold

Current Market Cap: £1.57B

See more insights into GNS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1